Chronic administration of cyclosporine a changes expression of BDNF and TrkB in rat hippocampus and midbrain

Neurochemical Research

Volumn 35, Issue 7, 2010, Pages 1098-1104

  Chen, Chien Chih ^a   Hsu, Li Wen ^b   Huang, Li Tung ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

BDNF; Depression; Immunosuppressive agent; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLOSPORIN A; MESSENGER RNA; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL VIABILITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; CYCLOSPORINE; DOWN-REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESENCEPHALON; RATS; RECEPTOR, TRKB; RNA, MESSENGER;

RATTUS;

EID: 77953231318     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0160-0     Document Type: Article

References (27)

1. P Ernfors KF Lee R Jaenisch 1994 Mice lacking brain-derived neurotrophic factor develop with sensory deficits Nature 368 147 150 10.1038/368147a0 1:CAS:528:DyaK2cXitV2ns7w%3D 8139657 (Pubitemid 24101525)
2. KR Jones I Farinas C Backus, et al. 1994 Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development Cell 76 989 999 10.1016/0092-8674(94)90377-8 1:CAS:528: DyaK2cXisVWjtbs%3D 8137432 (Pubitemid 24106380)
3. R Klein RJ Smeyne W Wurst, et al. 1993 Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death Cell 75 113 122 1:CAS:528:DyaK2cXltVyqug%3D%3D 8402890
4. DM Chuang 2005 The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials Ann N Y Acad Sci 1053 195 204 10.1196/annals.1344.018 1:CAS:528:DC%2BD28XotlKrsw%3D%3D 16179524 (Pubitemid 43031098)
5. MJ Webster MM Herman JE Kleinman, et al. 2006 BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan Gene Expr Patterns 6 941 951 10.1016/j.modgep.2006.03.009 1:CAS:528: DC%2BD28XpsVWrtLs%3D 16713371 (Pubitemid 44309446)
6. EM Chalovich JH Zhu J Caltagarone, et al. 2006 Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells J Biol Chem 281 17870 17881 10.1074/jbc.M602632200 1:CAS:528:DC%2BD28XmtFyktrk%3D 16621793 (Pubitemid 44035586)
7. YC Chang SI Rapoport JS Rao 2009 Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex Neurochem Res 34 536 541 10.1007/s11064-008-9817-3 1:CAS:528: DC%2BD1MXhsFOkur0%3D 18719996
8. D Faulds KL Goa P Benfield 1993 Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders Drugs 45 953 1040 10.2165/00003495-199345060-00007 1:CAS:528:DyaK3sXmtFKlsL0%3D 7691501 (Pubitemid 23219075)
9. AA Rossini DL Greiner JP Mordes 1999 Induction of immunologic tolerance for transplantation Physiol Rev 79 99 141 1:CAS:528:DyaK1MXhs1Cgu7o%3D 9922369
10. B Gabryel J Bernacki 2009 Effect of FK506 and cyclosporine A on the expression of BDNF, tyrosine kinase B and p75 neurotrophin receptors in astrocytes exposed to simulated ischemia in vitro Cell Biol Int 33 739 748 10.1016/j.cellbi.2009.04.006 1:CAS:528:DC%2BD1MXnsl2isr8%3D 19393753
11. K Miyata N Omori H Uchino, et al. 2001 Involvement of the brain-derived neurotrophic factor/TrkB pathway in neuroprotecive effect of cyclosporin A in forebrain ischemia Neuroscience 105 571 578 10.1016/S0306-4522(01)00225-1 1:CAS:528:DC%2BD3MXmtV2hs78%3D 11516824 (Pubitemid 32769823)
12. GL Bird J Meadows J Goka, et al. 1990 Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation J Neurol Neurosurg Psychiatry 53 1068 1071 10.1136/jnnp.53.12.1068 1:STN:280: DyaK3M7lsVOktg%3D%3D 2292700
13. PC de Groen AJ Aksamit J Rakela, et al. 1987 Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol N Engl J Med 317 861 866 3306386
14. BD Kahan SM Flechner MI Lorber, et al. 1987 Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years Transplantation 43 197 204 10.1097/00007890-198702000-00007 1:STN:280: DyaL2s7itFCqsQ%3D%3D 3544376
15. U Schmitt A Abou El-Ela LJ Guo, et al. 2006 Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp) J Neural Transm 113 787 801 10.1007/s00702-005-0367-4 1:CAS:528:DC%2BD28XmtlaisL0%3D 16252067 (Pubitemid 43962774)
16. S Telarovic M Mihanovic 2007 Cyclosporine-induced depressive psychosis in a liver transplant patient: a case report Lijec Vjesn 129 74 76 17557548
17. S Di Nuzzo M Zanni G De Panfilis 2007 Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept J Drugs Dermatol 6 1046 1047 17966184
18. A Menter A Gottlieb SR Feldman, et al. 2008 Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics J Am Acad Dermatol 58 826 850 10.1016/j.jaad.2008.02.039 18423260 (Pubitemid 351509656)
19. S von Horsten MS Exton J Voge, et al. 1998 Cyclosporine A affects open field behavior in DA rats Pharmacol Biochem Behav 60 71 76 10.1016/S0091- 3057(97)00467-X (Pubitemid 28236614)
20. E Abemayor N Sidell G Juillard 1989 Human medullary thyroid carcinoma. Initial characterization and in vitro differentiation of two new cell lines Arch Otolaryngol Head Neck Surg 115 478 483 1:STN:280:DyaL1M7ms1WmsA%3D%3D 2538133
21. PA Li H Uchino E Elmer, et al. 1997 Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia Brain Res 753 133 140 10.1016/S0006-8993(97)00005-X 1:CAS:528:DyaK2sXhslOmt74%3D 9125440 (Pubitemid 27156143)
22. MJ Kemper G Sparta GF Laube, et al. 2003 Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation Clin Transplant 17 130 134 10.1034/j.1399-0012.2003.00028.x 12709079 (Pubitemid 36833784)
23. RM Jindal JT Joseph MC Morris, et al. 2003 Noncompliance after kidney transplantation: a systematic review Transplant Proc 35 2868 2872 10.1016/j.transproceed.2003.10.052 1:STN:280:DC%2BD2c%2FgtlKksA%3D%3D 14697924 (Pubitemid 38102076)
24. RS Duman LM Monteggia 2006 A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 1116 1127 10.1016/j.biopsych.2006.02.013 1:CAS:528:DC%2BD28XmtVOisbc%3D 16631126
25. TJ Kingsbury LL Bambrick CD Roby, et al. 2007 Calcineurin activity is required for depolarization-induced, CREB-dependent gene transcription in cortical neurons J Neurochem 103 761 770 10.1111/j.1471-4159.2007.04801.x 1:CAS:528:DC%2BD2sXht1KqsLrJ 17666045 (Pubitemid 47498035)
26. F Karege G Vaudan M Schwald, et al. 2005 Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs Brain Res Mol Brain Res 136 29 37 10.1016/j.molbrainres. 2004.12.020 1:CAS:528:DC%2BD2MXktVGls7c%3D 15893584 (Pubitemid 40704606)
27. E Shimizu K Hashimoto N Okamura, et al. 2003 Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants Biol Psychiatry 54 70 75 10.1016/S0006-3223(03)00181-1 1:CAS:528:DC%2BD3sXkvF2jsro%3D 12842310 (Pubitemid 36776725)